Perlapine
Top View
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Development of Novel Serotonin 5-HT6 and Dopamine D2 Receptor
- In Vitro Pharmacology of Clinically Used CNS Active Drugs As Inverse
- Use of Combinations Comprising a Corticosteroid and a Pyrimidopyrimidine in the Treatment of Inflammatory Diseases
- 2019 Equine Prohibited Substances List
- Customs Tariff - Schedule Xxi - 1
- ARCI CLASSIFICATION PROGRAM V14.1
- A Quantitative Structure – Toxicity Relationship of Drugs on Rat Summary
- Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Rule
- KENTUCKY HORSE RACING Chapter: \810\008.020REG
- Wo 2007/044693 A2
- United States Patent (19) 11 4,138,484 Fuxe 45 Feb
- Targeting the Dopamine D Receptor in Schizophrenia
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors Or Are Selective for D 4 Receptors
- Sleep Apnea and CMV Driver Safety
- Joseph H. Porter · Adam J. Prus Editors the Behavioral Neuroscience of Drug Discrimination Current Topics in Behavioral Neurosciences
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances